EDSA EDESA BIOTECH INC revenue, earnings and financials
For the quarter ended June 30, 2026, EDESA BIOTECH INC reported revenue of n/a, net income of −$5.41M and diluted EPS of n/a; for the fiscal year ended September 2025 revenue was n/a.
EDSA annual revenue and earnings
- Fiscal year ended Sep 2025: revenue n/a, gross profit n/a, operating income −$7.91M, net income −$7.19M (margin n/a), EPS n/a
- Fiscal year ended Sep 2024: revenue n/a, gross profit n/a, operating income −$7.01M, net income −$6.17M (margin n/a), EPS n/a
- Fiscal year ended Sep 2023: revenue n/a, gross profit n/a, operating income −$9.22M, net income −$8.37M (margin n/a), EPS n/a
- Fiscal year ended Sep 2022: revenue n/a, gross profit n/a, operating income −$18.4M, net income −$17.5M (margin n/a), EPS n/a
- Fiscal year ended Sep 2021: revenue $0, gross profit n/a, operating income −$23.7M, net income −$13.3M (margin n/a), EPS −$1.10
EDSA quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$5.41M, EPS n/a
- Quarter ended Mar 31, 2026: revenue n/a, net income −$4.22M, EPS n/a
- Quarter ended Dec 31, 2025: revenue n/a, net income −$2.25M, EPS n/a
- Quarter ended Sep 30, 2025 (from the annual report): revenue n/a, net income −$2.23M, EPS n/a
- Quarter ended Jun 30, 2025: revenue n/a, net income −$1.75M, EPS n/a
- Quarter ended Mar 31, 2025: revenue n/a, net income −$1.59M, EPS n/a
- Quarter ended Dec 31, 2024: revenue n/a, net income −$1.62M, EPS n/a
- Quarter ended Sep 30, 2024 (from the annual report): revenue n/a, net income −$962K, EPS n/a
- Quarter ended Jun 30, 2024: revenue n/a, net income −$1.67M, EPS n/a
- Quarter ended Mar 31, 2024: revenue n/a, net income −$1.86M, EPS n/a
- Quarter ended Dec 31, 2023: revenue n/a, net income −$1.68M, EPS n/a
- Quarter ended Sep 30, 2023 (from the annual report): revenue n/a, net income −$1.72M, EPS n/a
- Quarter ended Jun 30, 2023: revenue n/a, net income −$1.98M, EPS n/a
- Quarter ended Mar 31, 2023: revenue n/a, net income −$2.33M, EPS n/a
- Quarter ended Dec 31, 2022: revenue n/a, net income −$2.33M, EPS n/a
- Quarter ended Sep 30, 2022 (from the annual report): revenue n/a, net income −$2.81M, EPS n/a
- Quarter ended Jun 30, 2022: revenue n/a, net income −$5.79M, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$4.57M, EPS n/a
- Quarter ended Dec 31, 2021: revenue n/a, net income −$4.38M, EPS −$0.33
- Quarter ended Jun 30, 2021: revenue $0, net income −$4.76M, EPS −$0.36
EDSA cash flow, buybacks and dividends
- Fiscal year ended Sep 2025: operating cash flow −$7.32M, share buybacks n/a
- Fiscal year ended Sep 2024: operating cash flow −$4.89M, share buybacks n/a
- Fiscal year ended Sep 2023: operating cash flow −$6.64M, share buybacks n/a
- Fiscal year ended Sep 2022: operating cash flow −$12.3M, share buybacks n/a
- Fiscal year ended Sep 2021: operating cash flow −$13.7M, share buybacks n/a
EDSA balance sheet
- Jun 30, 2026: cash $10.3M, total assets $12.7M, total liabilities n/a, shareholders' equity $8.81M
- Mar 31, 2026: cash $10.0M, total assets $12.4M, total liabilities n/a, shareholders' equity $10.2M
- Dec 31, 2025: cash $12.1M, total assets $14.7M, total liabilities n/a, shareholders' equity $14.0M
- Sep 30, 2025: cash $10.8M, total assets $13.5M, total liabilities n/a, shareholders' equity $12.5M
- Jun 30, 2025: cash $12.4M, total assets $14.8M, total liabilities n/a, shareholders' equity $14.1M
- Mar 31, 2025: cash $13.9M, total assets $16.5M, total liabilities n/a, shareholders' equity $15.5M
- Dec 31, 2024: cash $1.60M, total assets $4.16M, total liabilities n/a, shareholders' equity $2.26M
- Sep 30, 2024: cash $1.00M, total assets $3.81M, total liabilities $1.83M, shareholders' equity $1.98M
Is EDSA profitable?
No. EDESA BIOTECH INC lost $14.1M over the last four quarters.